Co-Diagnostics, Inc. (CODX) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Co-Diagnostics, Inc. (CODX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $6.7M, listed on NASDAQ, employing roughly 115 people, carrying a beta of 2.90 to the broader market. Co-Diagnostics, Inc. Led by Dwight Egan, public since 2017-07-12.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for CODX as of 2026-10-15; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →